Xigris Medicare Reimbursement: CMS Resisting New Severe Sepsis Code
Executive Summary
The Centers for Medicare & Medicaid Services plans to reimburse Lilly's sepsis agent Xigris using existing reimbursement codes
You may also be interested in...
Guilford Expects Medicare Payment Boost For Gliadel Starting Oct. 1
A new Medicare hospital payment category covering Guilford's Gliadel Wafer is expected to raise the reimbursement rate for the chemotherapy implant effective Oct. 1
Guilford Expects Medicare Payment Boost For Gliadel Starting Oct. 1
A new Medicare hospital payment category covering Guilford's Gliadel Wafer is expected to raise the reimbursement rate for the chemotherapy implant effective Oct. 1
Lilly Elevates Santini To Senior VP; “Access & Policy” Are Priorities
Lilly is placing additional emphasis on prescription drug access and pricing issues with the appointment of U.S. Operations President Gino Santini to senior VP-corporate strategy and policy